In the nearly four years since its launch, the Clinical Sequencing Exploratory Research (CSER) program has made significant strides in defining the role of genomics in medicine. CSER is nearing the end of its first round of research awards. To help identify the direction of a potential follow-up program, CSER investigators and colleagues recently met in Beth […]
Systemic juvenile idiopathic arthritis (sJIA) is a potentially life-threatening childhood disease, characterized by persistent joint swelling, pain and stiffness. Now, NHGRI Scientific Director Daniel Kastner, M.D., Ph.D., and his fellow investigators and colleagues have identified genomic variants that confer at least a two-fold increased risk of sJIA, sugg […]
Since 2004, the U.S. Surgeon General has recognized Thanksgiving as National Family Health History Day. This year, the National Human Genome Research Institute (NHGRI), along with Surgeon General Vice Admiral Vivek H. Murthy, M.D., M.B.A., encourages families to personalize their healthcare by sharing their family health history, and tracking illnesses from […]
As any good Star Trek fan knows, Mr. Spock was a "green-blooded Vulcan" because his hemoglobin was copper-based, unlike our iron-based human cells. But even humans have a little bit of copper in their blood. Now, a new paper based on research funded by the National Science Foundation (NSF) explores the role copper can play in feeding -- or starving […]
For the first time, researchers have attempted to measure all the material leaving and entering a mountain range over the course of more than a million years. They've discovered that erosion caused by glaciation during ice ages can, in the right circumstances, wear down mountains faster than plate tectonics can build them. The study, conducted by Integr […]
Groundbreaking effort for health care to help doctors diagnose and treat chronic diseases more quickly and accurately Full story at http://www.nsf.gov/news/special_reports/science_nation/predictivemedicine.jsp?WT.mc_id=USNSF_51This is an NSF News item.
A new study has shown that taking progesterone supplements during the first trimester of pregnancy does not improve the chances of maintaining pregnancy among women who have a history of unexplained recurrent miscarriage.
The researchers reported the results of a meta-analysis of 68 chemotherapy trials for cancer treatment between 2000 and 2006 - before the gradual introduction of targeted cancer therapies (drugs that target specific molecular pathways in tumour cells) from 2007, which today can be prescribed alongside cytotoxic drugs.
Funding Provided by:
The National Science Foundation
Ohio University | 510 Porter Hall
Athens, Ohio 45701 | 740 593-1120